<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02378129</url>
  </required_header>
  <id_info>
    <org_study_id>UFPel</org_study_id>
    <nct_id>NCT02378129</nct_id>
  </id_info>
  <brief_title>Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements</brief_title>
  <official_title>Evaluation of the Effectiveness of Dentin Hypersensitivity Treatment Using Glass Ionomer Cements: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Pelotas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Pelotas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and
      compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT
      (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White,
      Gloucester, UK) at 2-year follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will require to have at least two teeth in different hemiarchs with dentin
      hypersensitivity. Teeth will be randomized into 2 groups, receiving either Clinpro XT or the
      conventional glass ionomer cement Vidrion R. Prior to the desensitizing treatment (baseline),
      painful symptoms will be assessed by tactile and air blast tests using the Visual Analogue
      Scale (VAS). Treatment evaluations will be conducted up to 2-year post-treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Scores as measured by the Visual Analog Scale (VAS)</measure>
    <time_frame>Change from Baseline in Pain Scores at 20 minutes; at 7, 15, 21, 30 days; and after 3, 6, 12, 24 months.</time_frame>
    <description>Tactile and air blast tests to evaluate pain with VAS</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Dentin Hypersensitivity</condition>
  <arm_group>
    <arm_group_label>Clinpro XT (3M ESPE, Minnesota, USA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Resin-modified glass ionomer cement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vidrion R (SS White, Gloucester, UK)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional glass ionomer cement</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Resin-modified glass ionomer cement Clinpro XT</intervention_name>
    <description>Clinpro XT (3M ESPE, Minnesota, USA)</description>
    <arm_group_label>Clinpro XT (3M ESPE, Minnesota, USA)</arm_group_label>
    <other_name>Clinpro XT (3M Espe, USA)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glass Ionomer cement Vidrion R</intervention_name>
    <description>Vidrion R (SS White, Gloucester, UK)</description>
    <arm_group_label>Vidrion R (SS White, Gloucester, UK)</arm_group_label>
    <other_name>Vidrion R (SS White, Gloucester, UK)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female subjects between 18 and 70 years old

          -  At least 2 teeth with dentin hypersensitivity in two different hemiarchs

          -  Dental elements with hypersensitivity without any pulp alteration

          -  People who are not taking any medication and women who are not pregnant

          -  Patients without eating disorders or very acidic diets.

        Exclusion Criteria:

          -  Teeth with hypersensitivity that presented extensive or unsatisfactory restorations,
             fractures, periodontal alterations, caries lesions, orthodontic brackets, endodontic
             treatments, pulp alterations.

          -  Subjects who received any desensitizing therapy during the last 3 months

          -  Subjects being under analgesics/anti-inflammatory drugs at the time of the study

          -  Teeth with hypersensitivity and non-carious cervical lesions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>28 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rafael G Lund, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Pelotas</affiliation>
  </overall_official>
  <reference>
    <citation>Lund RG, Silva AF, Piva E, Da Rosa WL, Heckmann SS, Demarco FF. Clinical evaluation of two desensitizing treatments in southern Brazil: A 3-month follow-up. Acta Odontol Scand. 2013 Nov;71(6):1469-74. doi: 10.3109/00016357.2013.770919. Epub 2013 Jul 3.</citation>
    <PMID>24180588</PMID>
  </reference>
  <reference>
    <citation>Brännström M. The hydrodynamics of the dental tubule and pulp fluid: its significance in relation to dentinal sensitivity. Annu Meet Am Inst Oral Biol. 1966;23:219.</citation>
    <PMID>5228880</PMID>
  </reference>
  <reference>
    <citation>da Rosa WL, Lund RG, Piva E, da Silva AF. The effectiveness of current dentin desensitizing agents used to treat dental hypersensitivity: a systematic review. Quintessence Int. 2013 Jul;44(7):535-46. doi: 10.3290/j.qi.a29610. Review.</citation>
    <PMID>23616976</PMID>
  </reference>
  <reference>
    <citation>Que K, Guo B, Jia Z, Chen Z, Yang J, Gao P. A cross-sectional study: non-carious cervical lesions, cervical dentine hypersensitivity and related risk factors. J Oral Rehabil. 2013 Jan;40(1):24-32. doi: 10.1111/j.1365-2842.2012.02342.x. Epub 2012 Aug 7.</citation>
    <PMID>22882712</PMID>
  </reference>
  <reference>
    <citation>Orchardson R, Gillam DG. Managing dentin hypersensitivity. J Am Dent Assoc. 2006 Jul;137(7):990-8; quiz 1028-9. Review.</citation>
    <PMID>16803826</PMID>
  </reference>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2015</study_first_submitted>
  <study_first_submitted_qc>March 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2015</study_first_posted>
  <last_update_submitted>March 3, 2015</last_update_submitted>
  <last_update_submitted_qc>March 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Pelotas</investigator_affiliation>
    <investigator_full_name>Rafael Guerra Lund</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Dentin Sensitivity</keyword>
  <keyword>Dentin Desensitizing Agents</keyword>
  <keyword>Glass Ionomer Cements</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Dentin Sensitivity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

